vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and TELOS CORP (TLS). Click either name above to swap in a different company.

TELOS CORP is the larger business by last-quarter revenue ($46.8M vs $40.7M, roughly 1.2× PETMED EXPRESS INC). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -34.9%, a 8.9% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs -23.3%). TELOS CORP produced more free cash flow last quarter ($8.0M vs $-9.2M). Over the past eight quarters, TELOS CORP's revenue compounded faster (25.7% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.

PETS vs TLS — Head-to-Head

Bigger by revenue
TLS
TLS
1.2× larger
TLS
$46.8M
$40.7M
PETS
Growing faster (revenue YoY)
TLS
TLS
+100.6% gap
TLS
77.4%
-23.3%
PETS
Higher net margin
PETS
PETS
8.9% more per $
PETS
-26.0%
-34.9%
TLS
More free cash flow
TLS
TLS
$17.2M more FCF
TLS
$8.0M
$-9.2M
PETS
Faster 2-yr revenue CAGR
TLS
TLS
Annualised
TLS
25.7%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
TLS
TLS
Revenue
$40.7M
$46.8M
Net Profit
$-10.6M
$-16.3M
Gross Margin
23.3%
35.0%
Operating Margin
-25.7%
-39.6%
Net Margin
-26.0%
-34.9%
Revenue YoY
-23.3%
77.4%
Net Profit YoY
-1392.6%
-74.8%
EPS (diluted)
$-0.50
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
TLS
TLS
Q4 25
$40.7M
$46.8M
Q3 25
$44.4M
$51.4M
Q2 25
$51.2M
$36.0M
Q1 25
$50.8M
$30.6M
Q4 24
$52.0M
$26.4M
Q3 24
$58.0M
$23.8M
Q2 24
$66.2M
$28.5M
Q1 24
$65.1M
$29.6M
Net Profit
PETS
PETS
TLS
TLS
Q4 25
$-10.6M
$-16.3M
Q3 25
$-8.5M
$-2.1M
Q2 25
$-34.2M
$-9.5M
Q1 25
$-11.6M
$-8.6M
Q4 24
$-707.0K
$-9.3M
Q3 24
$2.3M
$-28.1M
Q2 24
$3.8M
$-7.8M
Q1 24
$-5.0M
$-7.4M
Gross Margin
PETS
PETS
TLS
TLS
Q4 25
23.3%
35.0%
Q3 25
28.0%
39.9%
Q2 25
28.1%
33.2%
Q1 25
29.9%
39.8%
Q4 24
31.0%
40.3%
Q3 24
32.3%
13.2%
Q2 24
28.8%
34.1%
Q1 24
29.3%
37.0%
Operating Margin
PETS
PETS
TLS
TLS
Q4 25
-25.7%
-39.6%
Q3 25
-18.9%
-4.8%
Q2 25
-66.7%
-27.5%
Q1 25
-11.9%
-29.5%
Q4 24
-0.9%
-37.6%
Q3 24
1.0%
-121.4%
Q2 24
6.6%
-30.3%
Q1 24
-5.9%
-28.5%
Net Margin
PETS
PETS
TLS
TLS
Q4 25
-26.0%
-34.9%
Q3 25
-19.2%
-4.1%
Q2 25
-66.7%
-26.5%
Q1 25
-22.9%
-28.1%
Q4 24
-1.4%
-35.4%
Q3 24
4.0%
-118.0%
Q2 24
5.7%
-27.2%
Q1 24
-7.7%
-24.9%
EPS (diluted)
PETS
PETS
TLS
TLS
Q4 25
$-0.50
$-0.22
Q3 25
$-0.41
$-0.03
Q2 25
$-1.65
$-0.13
Q1 25
$-0.56
$-0.12
Q4 24
$-0.03
$-0.13
Q3 24
$0.11
$-0.39
Q2 24
$0.18
$-0.11
Q1 24
$-0.24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
TLS
TLS
Cash + ST InvestmentsLiquidity on hand
$26.9M
$53.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$96.0M
Total Assets
$88.0M
$139.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
TLS
TLS
Q4 25
$26.9M
$53.2M
Q3 25
$36.1M
$59.0M
Q2 25
$41.1M
$57.0M
Q1 25
$54.7M
$57.8M
Q4 24
$50.1M
$54.6M
Q3 24
$52.0M
$69.8M
Q2 24
$46.0M
$80.1M
Q1 24
$55.3M
$93.9M
Stockholders' Equity
PETS
PETS
TLS
TLS
Q4 25
$32.8M
$96.0M
Q3 25
$43.1M
$119.7M
Q2 25
$51.5M
$118.4M
Q1 25
$85.1M
$126.1M
Q4 24
$96.2M
$127.1M
Q3 24
$96.4M
$129.5M
Q2 24
$93.5M
$149.1M
Q1 24
$96.7M
$154.4M
Total Assets
PETS
PETS
TLS
TLS
Q4 25
$88.0M
$139.9M
Q3 25
$100.3M
$164.3M
Q2 25
$109.8M
$165.0M
Q1 25
$148.7M
$158.1M
Q4 24
$144.8M
$158.2M
Q3 24
$146.0M
$166.3M
Q2 24
$152.7M
$182.4M
Q1 24
$169.9M
$195.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
TLS
TLS
Operating Cash FlowLast quarter
$-9.2M
$8.0M
Free Cash FlowOCF − Capex
$-9.2M
$8.0M
FCF MarginFCF / Revenue
-22.7%
17.0%
Capex IntensityCapex / Revenue
0.1%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
TLS
TLS
Q4 25
$-9.2M
$8.0M
Q3 25
$-2.2M
$9.1M
Q2 25
$-12.3M
$7.0M
Q1 25
$7.0M
$6.1M
Q4 24
$-1.2M
$-10.5M
Q3 24
$7.4M
$-7.1M
Q2 24
$-8.5M
$-8.0M
Q1 24
$7.1M
$-350.0K
Free Cash Flow
PETS
PETS
TLS
TLS
Q4 25
$-9.2M
$8.0M
Q3 25
$-4.8M
$8.7M
Q2 25
$-13.6M
$6.8M
Q1 25
$4.6M
$6.0M
Q4 24
$-1.9M
$-12.4M
Q3 24
$6.1M
$-7.1M
Q2 24
$-9.2M
$-8.2M
Q1 24
$5.9M
$-447.0K
FCF Margin
PETS
PETS
TLS
TLS
Q4 25
-22.7%
17.0%
Q3 25
-10.8%
16.9%
Q2 25
-26.5%
19.0%
Q1 25
9.1%
19.5%
Q4 24
-3.7%
-47.0%
Q3 24
10.6%
-30.0%
Q2 24
-13.9%
-28.9%
Q1 24
9.0%
-1.5%
Capex Intensity
PETS
PETS
TLS
TLS
Q4 25
0.1%
0.1%
Q3 25
5.9%
0.9%
Q2 25
2.5%
0.4%
Q1 25
4.7%
0.4%
Q4 24
1.5%
7.1%
Q3 24
2.2%
0.2%
Q2 24
1.0%
0.8%
Q1 24
1.9%
0.3%
Cash Conversion
PETS
PETS
TLS
TLS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

TLS
TLS

Security Solutions Segment$44.8M96%
Secure Networks Segment$1.9M4%

Related Comparisons